Using biology of disease to understand and guide therapy of JIA
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 23 (5) , 599-608
- https://doi.org/10.1016/j.berh.2009.07.003
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Interleukin‐17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbersArthritis & Rheumatism, 2008
- Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2007
- Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional studyAnnals of the Rheumatic Diseases, 2007
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent MechanismsThe Journal of Experimental Medicine, 2003
- β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trialThe Lancet, 2001
- Type 1 T regulatory cellsImmunological Reviews, 2001
- Juvenile chronic arthritisThe Lancet, 1998
- Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptidesImmunity, 1994